This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Document Few May Read And Why It Is The Most Important Thing In Your SNP

I was sitting with a model of care (MOC) recently — not skimming it, actually reading it — and it brought back a conversation I had with a colleague that I have not been able to shake.

United States Healthcare

AC

Ankura Consulting Group LLC

CMS Finalizes Rate Notice For Medicare Parts C And D (CY 2027)

On April 6, 2026, the Centers for Medicare and Medicaid Services (CMS) circulated the Announcement of Calendar Year (CY) 2027 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies...

United States Healthcare

CM

Crowell & Moring LLP

From Guidance To The Galley: CMS Urges DGA‑Aligned Menus And Procurement Under Hospital CoPs

On March 30, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a Quality & Safety Special Alert Memo (QSSAM) to hospitals and Critical Access Hospital (CAH) providers titled...

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Pitfalls And Traps For Fraud In Telemedicine

In March 2026, the owner of a telemedicine company admitted to organizing and leading a long-running fraud scheme in which he ordered unnecessary orthotic...

United States Healthcare

HK

Holland & Knight

Are Your Digital Front Door And Virtual Health Services Accessible?

United States Healthcare

HK

Holland & Knight

CMS Proposes Significant Medicare Advantage Payment And Compliance Changes For 2027

United States Healthcare

CH

Clark Hill

Teva Receives FDA Approval Of Denosumab Biosimilar And Filing Acceptances By FDA And EMA For Omalizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

A Hard Pill To Swallow: 100% Tariffs Hit Pharma

United States Healthcare

AF

ArentFox Schiff

States Continue To Advance New PBM And Drug Pricing Legislation In 2026

United States Healthcare

M

Mintz

Structuring Discounts Arrangements In Compliance With Federal Anti-Kickback Law: OIG's Advisory Opinion 25-11

United States Healthcare

FL

Foley & Lardner

FTC Mandates Point-of-Sale Rebates For Prescription Drugs

United States Healthcare

HB

Hall Benefits Law

Cosmetics Under The Microscope: FDA’s Expanding Regulatory Reach Under MoCRA

United States Healthcare

CM

Crowell & Moring LLP

Amgen And Shanghai Henlius/Organon Settle Denosumab BPCIA Litigation

United States Healthcare

GP

Goodwin Procter LLP

Federal And State Policymakers Push Forward With PBM And Drug Pricing Reform Even In The Wake Of Sweeping Actions Earlier This Year

United States Healthcare

M

Mintz

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Healthcare

Pitfalls And Traps For Fraud In Telemedicine

In March 2026, the owner of a telemedicine company admitted to organizing and leading a long-running fraud scheme in which he ordered unnecessary orthotic...

United States Healthcare

HK

Holland & Knight

The Document Few May Read And Why It Is The Most Important Thing In Your SNP

I was sitting with a model of care (MOC) recently — not skimming it, actually reading it — and it brought back a conversation I had with a colleague that I have not been able to shake.

United States Healthcare

AC

Ankura Consulting Group LLC

Are Your Digital Front Door And Virtual Health Services Accessible?

When considering how patients physically enter a hospital or physician office, state and federal law requires that disability accessibility is implemented in the structure's design and construction.

United States Healthcare

HK

Holland & Knight

CMS Finalizes Rate Notice For Medicare Parts C And D (CY 2027)

United States Healthcare

CM

Crowell & Moring LLP

From Guidance To The Galley: CMS Urges DGA‑Aligned Menus And Procurement Under Hospital CoPs

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Industry Voices—Hospitals Are Fueling AI Innovation, Should They Own A Piece Of It?

United States Technology

SM

Sheppard, Mullin, Richter & Hampton LLP

A Hard Pill To Swallow: 100% Tariffs Hit Pharma

United States Healthcare

AF

ArentFox Schiff

Hemp Product Use In Medicare: CMS Greenlights Pilot Program Under The Substance Access Beneficiary Engagement Incentive

United States Cannabis

FL

Foley & Lardner

FinCEN Advisory Warns Financial Institutions Of Healthcare Fraud Targeting Medicare And Medicaid

United States Government

BB

Bass, Berry & Sims

See more

Food and Drugs Law

The Document Few May Read And Why It Is The Most Important Thing In Your SNP

I was sitting with a model of care (MOC) recently — not skimming it, actually reading it — and it brought back a conversation I had with a colleague that I have not been able to shake.

United States Healthcare

AC

Ankura Consulting Group LLC

CMS Finalizes Rate Notice For Medicare Parts C And D (CY 2027)

On April 6, 2026, the Centers for Medicare and Medicaid Services (CMS) circulated the Announcement of Calendar Year (CY) 2027 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies...

United States Healthcare

CM

Crowell & Moring LLP

From Guidance To The Galley: CMS Urges DGA‑Aligned Menus And Procurement Under Hospital CoPs

On March 30, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a Quality & Safety Special Alert Memo (QSSAM) to hospitals and Critical Access Hospital (CAH) providers titled...

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

New Advertising Code For Food Products

United States Media & IT

GA

Global Advertising Lawyers Alliance (GALA)

A Hard Pill To Swallow: 100% Tariffs Hit Pharma

United States Healthcare

AF

ArentFox Schiff

States Continue To Advance New PBM And Drug Pricing Legislation In 2026

United States Healthcare

M

Mintz

Teva Receives FDA Approval Of Denosumab Biosimilar And Filing Acceptances By FDA And EMA For Omalizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

EPA Proposes Sixth SDWA Contaminant Candidate List, Kicking Off Potentially Significant Consequences For Multiple Industries

United States Environment

BD

Beveridge & Diamond

FDA Turns Up The Heat On GLP 1 Dupes Sold "For Research Use Only," Finds Intended Use Suggests Otherwise

United States Media & IT

KD

Kelley Drye & Warren LLP

See more

Life Sciences, Biotechnology & Nanotechnology

A Hard Pill To Swallow: 100% Tariffs Hit Pharma

While Section 232 tariffs have so far been largely a metals-and-autos story, pharma has now officially joined the narrative.

United States Healthcare

AF

ArentFox Schiff

CMS Proposes Significant Medicare Advantage Payment And Compliance Changes For 2027

The Centers for Medicare & Medicaid Services (CMS) has issued its Advance Notice and related rulemaking for the Medicare Advantage (MA) and Part D programs for plan year 2027.

United States Healthcare

CH

Clark Hill

Structuring Discounts Arrangements In Compliance With Federal Anti-Kickback Law: OIG's Advisory Opinion 25-11

Offering discounts on pricing of medical products is often proposed as an advantageous business strategy in the health care industry.

United States Healthcare

FL

Foley & Lardner

Amgen And Shanghai Henlius/Organon Settle Denosumab BPCIA Litigation

United States Healthcare

GP

Goodwin Procter LLP

Regulatory Horizons: Supply Chain Sovereignty: How U.S. And EU Regulatory Priorities Are Reshaping Life Sciences Manufacturing (Podcast)

United States Healthcare

B

BakerHostetler

Ohio Legislatures Sign PBM Reform Into Law

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Trade Winds Shift For Pharma: Understanding The Section 232 Tariff Proclamation On Pharmaceuticals

United States International

AP

Arnold & Porter

Trump Administration Announces Tariffs On Imported Patented Medication And Pharmaceutical Ingredients Under Section 232 Of The Trade Expansion Act Of 1962

United States International

MB

Mayer Brown

FDA Presses Forward On Incorporating Patient Preferences In Device Decision Making, Releases Updated Final Guidance

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

See more

Latest Videos

See more

PBM Reform 2026: What Recent Legislation Means For The Industry (Video)

M

Mintz

In The Know: The Clean Beauty Trend Becomes State Law (Video)

LL

Loeb & Loeb LLP

GT Legal Food Talk Episode 30: Navigating Liquor Licensing: Inside The Legal Food & Beverage Landscape (Podcast)

GT

Greenberg Traurig, LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Video)

W

WilmerHale

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Upcoming Events

The Biology Of Trade: Biotech & Life Science Materials

United States Healthcare

BG

Braumiller Law Group, PLLC

Rising CMS Scrutiny: What Labs Need To Know

United States Healthcare

SR

McDermott Will & Schulte

Speaking Engagement

31st Annual Executive War College On Diagnostics, Clinical Laboratory And Pathology Management - The Dark Intelligence Group

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

NAMCP 2026 Spring Managed Care Forum

United States Healthcare

SR

McDermott Will & Schulte

Speaking Engagement

30th Annual Compliance Institute

United States Healthcare

W

WilmerHale

NC ASHRM 2026 Spring Conference

United States Healthcare

YM

Young Moore and Henderson

Managing Pharmacy Benefits And Specialty Delivery – For Payers, Pharmacies And Patients: What Is The Future

United States Healthcare

HK

Holland & Knight

Asembia’s AXS26 Summit

United States Healthcare

SR

McDermott Will & Schulte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More